STERIS plc (Ireland)

199.12-1.16-0.58%Vol 823.47K1Y Perf 30.54%
Jun 18th, 2021 16:00 DELAYED
BID195.00 ASK212.44
Open199.60 Previous Close200.28
Pre-Market- After-Market199.12
 - -  - -%
Target Price
228.40 
Analyst Rating
Moderate Buy 2.20
Potential %
14.70 
Finscreener Ranking
★★+     47.54
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★★     52.31
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★★★+     63.43
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
★★+     41.76
Market Cap17.00B 
Earnings Rating
Sell
Price Range Ratio 52W %
75.05 
Earnings Date
2nd Aug 2021

Today's Price Range

197.54200.39

52W Range

146.12216.74

5 Year PE Ratio Range

26.6074.50

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
0.30%
1 Month
5.13%
3 Months
6.34%
6 Months
7.69%
1 Year
30.54%
3 Years
86.53%
5 Years
196.67%
10 Years
540.93%

TickerPriceChg.Chg.%
STE199.12-1.1600-0.58
AAPL130.46-1.3300-1.01
GOOG2 511.35-16.0700-0.64
MSFT259.43-1.4700-0.56
XOM60.40-1.5900-2.56
WFC41.75-1.0400-2.43
JNJ161.98-3.2400-1.96
FB329.66-6.8500-2.04
GE12.78-0.2200-1.69
JPM147.92-3.8400-2.53
Financial StrengthValueIndustryS&P 500US Markets
1.40
2.10
0.31
0.46
14.90
Leverage Ratio 1.60
ProfitabilityValueIndustryS&P 500US Markets
43.20
17.90
24.90
13.20
12.79
RevenueValueIndustryS&P 500US Markets
3.11B
31.18
6.16
6.32
DividendsValueIndustryS&P 500US Markets
0.81
1.60
9.07
9.91
Payout ratio30.00
Earnings HistoryEstimateReportedSurprise %
Q04 20211.801.63-9.44
Q03 20211.561.7310.90
Q02 20211.241.4819.35
Q01 20210.971.3135.05
Q04 20201.571.644.46
Q03 20201.431.451.40
Q02 20201.261.324.76
Q01 20201.111.2310.81
Earnings Per EndEstimateRevision %Trend
6/2021 QR1.50-6.25Negative
9/2021 QR1.8510.12Positive
3/2022 FY7.507.60Positive
3/2023 FY8.518.82Positive
Next Report Date2nd Aug 2021
Estimated EPS Next Report1.50
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume823.47K
Shares Outstanding85.38M
Trades Count12.98K
Dollar Volume109.03M
Avg. Volume690.96K
Avg. Weekly Volume635.14K
Avg. Monthly Volume935.33K
Avg. Quarterly Volume752.30K

STERIS plc (Ireland) (NYSE: STE) stock closed at 199.12 per share at the end of the most recent trading day (a -0.58% change compared to the prior day closing price) with a volume of 849.92K shares and market capitalization of 17.00B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 13000 people. STERIS plc (Ireland) CEO is Walter M. Rosebrough.

The one-year performance of STERIS plc (Ireland) stock is 30.54%, while year-to-date (YTD) performance is 5.05%. STE stock has a five-year performance of 196.67%. Its 52-week range is between 146.12 and 216.74, which gives STE stock a 52-week price range ratio of 75.05%

STERIS plc (Ireland) currently has a PE ratio of 42.90, a price-to-book (PB) ratio of 5.10, a price-to-sale (PS) ratio of 6.36, a price to cashflow ratio of 24.70, a PEG ratio of 2.32, a ROA of 6.43%, a ROC of 8.13% and a ROE of 10.59%. The company’s profit margin is 12.79%, its EBITDA margin is 24.90%, and its revenue ttm is $3.11 Billion , which makes it $31.18 revenue per share.

Of the last four earnings reports from STERIS plc (Ireland), there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $1.50 for the next earnings report. STERIS plc (Ireland)’s next earnings report date is 02nd Aug 2021.

The consensus rating of Wall Street analysts for STERIS plc (Ireland) is Moderate Buy (2.2), with a target price of $228.4, which is +14.70% compared to the current price. The earnings rating for STERIS plc (Ireland) stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

STERIS plc (Ireland) has a dividend yield of 0.81% with a dividend per share of $1.60 and a payout ratio of 30.00%.

STERIS plc (Ireland) has a Buy technical analysis rating based on Technical Indicators (ADX : 9.43, ATR14 : 3.34, CCI20 : 96.69, Chaikin Money Flow : -0.17, MACD : 0.49, Money Flow Index : 56.43, ROC : 4.15, RSI : 54.61, STOCH (14,3) : 79.57, STOCH RSI : 0.27, UO : 50.32, Williams %R : -20.43), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of STERIS plc (Ireland) in the last 12-months were: Cary L Majors (Option Excercise at a value of $209 160), Cary L Majors (Sold 7 573 shares of value $1 230 997 ), Daniel A. Carestio (Option Excercise at a value of $2 630 085), Daniel A. Carestio (Sold 36 500 shares of value $6 448 703 ), David B. Lewis (Option Excercise at a value of $49 312), David B. Lewis (Sold 1 560 shares of value $302 312 ), J. Adam Zangerle (Option Excercise at a value of $655 727), J. Adam Zangerle (Sold 14 252 shares of value $2 514 856 ), Jacqueline B. Kosecoff (Option Excercise at a value of $98 655), Jacqueline B. Kosecoff (Sold 3 121 shares of value $601 073 ), Julia K. Madsen (Option Excercise at a value of $299 351), Julia K. Madsen (Sold 4 900 shares of value $992 636 ), Julia Madsen (Option Excercise at a value of $299 351), Julia Madsen (Sold 4 900 shares of value $992 636 ), Karen L. Burton (Option Excercise at a value of $0), Karen L. Burton (Sold 4 602 shares of value $825 682 ), Michael J. Tokich (Option Excercise at a value of $1 498 560), Michael J. Tokich (Sold 28 000 shares of value $5 268 945 ), Richard C. Breeden (Sold 45 000 shares of value $6 904 302 ), Walter M. Rosebrough (Option Excercise at a value of $9 819 226), Walter M. Rosebrough (Sold 142 085 shares of value $22 670 740 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (40.00 %)
2 (50.00 %)
2 (50.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
3 (60.00 %)
2 (50.00 %)
2 (50.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
2.20
Moderate Buy
2.00
Moderate Buy
2.00

STERIS plc (Ireland)

Steris is an Ireland-domiciled medical device company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its 2015 inversion to Ireland, the firm continues to derive roughly 70% of revenue from its U.S. operations, 10% from the United Kingdom, and the remaining 20% from other international regions.

CEO: Walter M. Rosebrough

Telephone: +353 12322000

Address: 70 Sir John Rogerson's Quay, Dublin D02 R296, , IE

Number of employees: 13 000

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

64%36%

Bearish Bullish

56%44%

Bearish Bullish

64%36%

News

Stocktwits